{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:16Z","timestamp":1791225976091,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Health Department of \u201cGobierno de Navarra\u201d","award":["28\/2007"],"award-info":[{"award-number":["28\/2007"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PS09\/01083"],"award-info":[{"award-number":["PS09\/01083"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI070326"],"award-info":[{"award-number":["PI070326"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["FI08\/00432"],"award-info":[{"award-number":["FI08\/00432"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.121","type":"journal-article","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T00:15:08Z","timestamp":1315786508000},"page":"8222-8229","source":"Crossref","is-referenced-by-count":87,"title":["Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice"],"prefix":"10.1016","volume":"29","author":[{"given":"A.I.","family":"Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pardo-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gamazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2011.08.121_bib0005","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.08.121_bib0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.08.121_bib0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/QCO.0b013e3282f88b92","article-title":"Shigellosis: the current status of vaccine development","volume":"21","author":"Kweon","year":"2008","journal-title":"Curr Opin Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.08.121_bib0020","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1586\/erv.09.127","article-title":"Inactivated and subunit vaccines to prevent shigellosis","volume":"8","author":"Kaminski","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.08.121_bib0025","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1128\/CVI.00164-10","article-title":"Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation","volume":"17","author":"Tamayo","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2011.08.121_bib0030","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1016\/j.vaccine.2007.03.025","article-title":"Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice","volume":"25","author":"Ochoa","year":"2007","journal-title":"Vaccine"},{"issue":"September (9\u201310)","key":"10.1016\/j.vaccine.2011.08.121_bib0035","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1166\/jnn.2006.471","article-title":"Development of a novel vaccine delivery system based on Gantrez nanoparticles","volume":"6","author":"Gomez","year":"2006","journal-title":"J Nanosci Nanotechnol"},{"issue":"August (1\u20132)","key":"10.1016\/j.vaccine.2011.08.121_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.03.033","article-title":"Salmonella-like bioadhesive nanoparticles","volume":"106","author":"Salman","year":"2005","journal-title":"J Control Release"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2011.08.121_bib0045","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2007.05.020","article-title":"Gantrez AN nanoparticles as an adjuvant for oral immunotherapy with allergens","volume":"25","author":"Gomez","year":"2007","journal-title":"Vaccine"},{"issue":"October (13)","key":"10.1016\/j.vaccine.2011.08.121_bib0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.08.121_bib0055","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1128\/IAI.01382-05","article-title":"Membrane vesicles shed by Legionella pneumophila inhibit fusion of phagosomes with lysosomes","volume":"74","author":"Fernandez-Moreira","year":"2006","journal-title":"Infect Immun"},{"issue":"November (23)","key":"10.1016\/j.vaccine.2011.08.121_bib0060","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1038\/sj.emboj.7600471","article-title":"Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells","volume":"23","author":"Kesty","year":"2004","journal-title":"EMBO J"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2011.08.121_bib0065","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/jb.177.14.3998-4008.1995","article-title":"Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion","volume":"177","author":"Kadurugamuwa","year":"1995","journal-title":"J Bacteriol"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2011.08.121_bib0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0092-8674(03)00754-2","article-title":"Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin","volume":"115","author":"Wai","year":"2003","journal-title":"Cell"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.08.121_bib0075","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/IAI.63.6.2382-2386.1995","article-title":"Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection","volume":"63","author":"Mallett","year":"1995","journal-title":"Infect Immun"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2011.08.121_bib0080","doi-asserted-by":"crossref","first-page":"12489","DOI":"10.1074\/jbc.275.17.12489","article-title":"Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles","volume":"275","author":"Horstman","year":"2000","journal-title":"J Biol Chem"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.08.121_bib0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0264-410X(90)90083-X","article-title":"Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine","volume":"8","author":"Bahnemann","year":"1990","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.08.121_bib0090","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1128\/IAI.57.5.1419-1426.1989","article-title":"Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis","volume":"57","author":"Gamazo","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.08.121_bib0095","first-page":"237","article-title":"Micromethods for the characterization of lipid A-core and O-antigen lipopolysaccharide","volume":"347","author":"Marolda","year":"2006","journal-title":"Methods Mol Biol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.08.121_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/abio.1998.2961","article-title":"Quantification of bacterial lipopolysaccharides by the purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation","volume":"267","author":"Lee","year":"1999","journal-title":"Anal Biochem"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.08.121_bib0105","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1074\/jbc.M308633200","article-title":"Lipopolysaccharide 3-deoxy-D-manno-octulosonic acid (Kdo) core determines bacterial association of secreted toxins","volume":"279","author":"Horstman","year":"2004","journal-title":"J Biol Chem"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.08.121_bib0110","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1128\/IAI.65.10.4005-4010.1997","article-title":"Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation","volume":"65","author":"Bahrani","year":"1997","journal-title":"Infect Immun"},{"issue":"October (3)","key":"10.1016\/j.vaccine.2011.08.121_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-3659(02)00015-9","article-title":"AN as a new polymer for the preparation of ligand-nanoparticle conjugates","volume":"83","author":"Arbos","year":"2002","journal-title":"J Control Release"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.08.121_bib0120","first-page":"1","article-title":"Study of the antigenic relations between Yersina enterocolitica serotype 9 and other Gram negative bacterial strains","volume":"27","author":"Diaz","year":"1974","journal-title":"Microbiol Esp"},{"issue":"August (33\u201334)","key":"10.1016\/j.vaccine.2011.08.121_bib0125","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1016\/j.vaccine.2006.03.026","article-title":"Role of Shigella flexneri 2a 34kDa outer membrane protein in induction of protective immune response","volume":"24","author":"Mukhopadhaya","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2011.08.121_bib0130","doi-asserted-by":"crossref","first-page":"e8223","DOI":"10.1371\/journal.pone.0008223","article-title":"The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells","volume":"4","author":"Al-Hasani","year":"2009","journal-title":"PLoS One"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.08.121_bib0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2958.1995.tb02301.x","article-title":"Enhanced secretion through the Shigella flexneri Mxi-Spa translocon leads to assembly of extracellular proteins into macromolecular structures","volume":"16","author":"Parsot","year":"1995","journal-title":"Mol Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.08.121_bib0140","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/AAC.42.6.1476","article-title":"Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles","volume":"42","author":"Kadurugamuwa","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2011.08.121_bib0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.08.121_bib0150","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/IAI.72.11.6586-6588.2004","article-title":"Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children","volume":"72","author":"Canh","year":"2004","journal-title":"Infect Immun"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.08.121_bib0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.femsre.2003.07.002","article-title":"Shigella flexneri infection: pathogenesis and vaccine development","volume":"28","author":"Jennison","year":"2004","journal-title":"FEMS Microbiol Rev"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.08.121_bib0160","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/515150","article-title":"Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri","volume":"28","author":"Sansonetti","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.08.121_bib0165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/00365549309008545","article-title":"Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients","volume":"25","author":"Li","year":"1993","journal-title":"Scand J Infect Dis"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2011.08.121_bib0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.08.121_bib0175","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J Immunol"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.08.121_bib0180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.vaccine.2006.07.047","article-title":"Stationary phase culture supernatant containing membrane vesicles induced immunity to rainbow trout Oncorhynchus mykiss fry syndrome","volume":"25","author":"Aoki","year":"2007","journal-title":"Vaccine"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.08.121_bib0185","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bbrc.2009.10.081","article-title":"Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity","volume":"390","author":"Zhang","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"June (Suppl 2)","key":"10.1016\/j.vaccine.2011.08.121_bib0190","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.08.121_bib0195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00032-07","article-title":"Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion","volume":"21","author":"Schroeder","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2011.08.121_bib0200","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.molimm.2006.04.007","article-title":"Porin of Shigella dysenteriae activates mouse peritoneal macrophage through Toll-like receptors 2 and 6 to induce polarized type I response","volume":"44","author":"Biswas","year":"2007","journal-title":"Mol Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.08.121_bib0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.icb7100025","article-title":"Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?","volume":"85","author":"Phalipon","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.08.121_bib0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1586\/erv.11.10","article-title":"Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines","volume":"10","author":"Sanders","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.08.121_bib0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1192","article-title":"Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells","volume":"6","author":"Rimoldi","year":"2005","journal-title":"Nat Immunol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.08.121_bib0220","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.08.121_bib0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.08.121_bib0230","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2008.02.063","article-title":"Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection","volume":"26","author":"Bungener","year":"2008","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.08.121_bib0235","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.08.121_bib0240","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/IAI.59.7.2341-2350.1991","article-title":"Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides","volume":"59","author":"Oberhelman","year":"1991","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.08.121_bib0245","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nri2797","article-title":"T cells: TLRs deliver a direct hit to TH17 cells","volume":"10","author":"Bird","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"February (7335)","key":"10.1016\/j.vaccine.2011.08.121_bib0250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.08.121_bib0255","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.4049\/jimmunol.0900978","article-title":"Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity","volume":"184","author":"Sellge","year":"2010","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T16:39:42Z","timestamp":1592930382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11013983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":51,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11013983"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.121","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}